loading...| Preferred Name |
Signaling by EGFR in Cancer |
|
| Synonyms |
|
|
| Definitions |
Edited: Haw, R, 2011-11-07 Edited: Wu, G, 2011-11-07 Edited: Jassal, B, 2011-11-07 Authored: Orlic-Milacic, M, 2011-11-04 Edited: D'Eustachio, P, 2011-11-07 The pathway "Signaling by EGFR in Cancer" shows "Signaling by constitutively active EGFR" in parallel with "Signaling by EGFR". This allows users to compare signaling by constitutively active EGFR cancer mutants with the wild-type EGFR protein. Red lines emphasize cancer related events and physical entities, while wild-type entities and events are shaded. Please refer to "Signaling by constitutively active EGFR" and "Signaling by EGFR" for detailed pathway summations. Edited: Gillespie, ME, 2011-11-07 Edited: Matthews, L, 2011-11-07 Reviewed: Greulich, H, 2011-11-15 Reviewed: Savas, S, 2011-11-15 |
|
| ID |
http://purl.obolibrary.org/obo/HINO_0015991 |
|
| comment |
Edited: Haw, R, 2011-11-07 Edited: Wu, G, 2011-11-07 Edited: Jassal, B, 2011-11-07 Authored: Orlic-Milacic, M, 2011-11-04 Edited: D'Eustachio, P, 2011-11-07 The pathway "Signaling by EGFR in Cancer" shows "Signaling by constitutively active EGFR" in parallel with "Signaling by EGFR". This allows users to compare signaling by constitutively active EGFR cancer mutants with the wild-type EGFR protein. Red lines emphasize cancer related events and physical entities, while wild-type entities and events are shaded. Please refer to "Signaling by constitutively active EGFR" and "Signaling by EGFR" for detailed pathway summations. Edited: Gillespie, ME, 2011-11-07 Edited: Matthews, L, 2011-11-07 Reviewed: Greulich, H, 2011-11-15 Reviewed: Savas, S, 2011-11-15 |
|
| definition source |
Reactome, http://www.reactome.org |
|
| label |
Signaling by EGFR in Cancer |
|
| located_in | ||
| prefixIRI |
HINO:0015991 |
|
| prefLabel |
Signaling by EGFR in Cancer |
|
| seeAlso |
Reactome Database ID Release 431643713 ReactomeREACT_115871 |
|
| subClassOf | ||
| has_part |